Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Jan;9(1):81–88. doi: 10.1128/aac.9.1.81

Viridins, Bacteriocins of Alpha-Hemolytic Streptococci: Isolation, Characterization, and Partial Purification

Adnan S Dajani *, May C Tom †, David J Law †
PMCID: PMC429479  PMID: 1259394

Abstract

Bacteriocin-like activities were detected in 78% of 120 alpha-hemolytic streptococcal isolates. Inhibitory substances from three such isolates (one Streptococcus sanguis strain and two S. mitis strains) were investigated further and termed viridins (A, B, and C). The viridins were unique among bacteriocins of gram-positive bacteria in that they inhibited many gram-negative bacteria in addition to inhibition of a variety of gram-positive organisms. Viridins were obtained in a cell-free state only after mechanical disruption of bacteriocinogenic cells but could not be isolated from supernatant fluids of cultures of such bacteria or from freeze-thaw liquor of agar on which the bacteria had been grown. Viridin B could be partially purified by ammonium sulfate precipitation and by gel filtration on a Sephadex G-100 column. This bacteriocin had some unusual properties including heat lability, a narrow pH range of activity, and lack of adsorptive capacity to susceptible bacteria. Although viridin B was bactericidal to a Neisseria sicca strain, it was only bacteriostatic against a coagulase-negative staphylococcus.

Full text

PDF

Images in this article

83Image
on p.83

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crowe C. C., Sanders W. E., Jr, Longley S. Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus. J Infect Dis. 1973 Oct;128(4):527–532. doi: 10.1093/infdis/128.4.527. [DOI] [PubMed] [Google Scholar]
  2. Dajani A. S., Gray E. D., Wannamaker L. W. Bactericidal substance from Staphylococcus aureus. Biological properties. J Exp Med. 1970 May 1;131(5):1004–1015. doi: 10.1084/jem.131.5.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dajani A. S., Wannamaker L. W. Demonstration of a bactericidal substance against beta-hemolytic streptococci in supernatant fluids of staphylococcal cultures. J Bacteriol. 1969 Mar;97(3):985–991. doi: 10.1128/jb.97.3.985-991.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dajani A. S., Wannamaker L. W. Kinetic studies on the interaction of bacteriophage type 71 staphylococcal bacteriocin with susceptible bacteria. J Bacteriol. 1973 May;114(2):738–742. doi: 10.1128/jb.114.2.738-742.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gagliano V. J., Hinsdill R. D. Characterization of a Staphylococcus aureus bacteriocin. J Bacteriol. 1970 Oct;104(1):117–125. doi: 10.1128/jb.104.1.117-125.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hale E. M., Hinsdill R. D. Biological activity of staphylococcin 162: bacteriocin from Staphylococcus aureus. Antimicrob Agents Chemother. 1975 Jan;7(1):74–81. doi: 10.1128/aac.7.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hale E. M., Hinsdill R. D. Characterization of a bacteriocin from Staphylococcus aureus strain 462. Antimicrob Agents Chemother. 1973 Dec;4(6):634–640. doi: 10.1128/aac.4.6.634. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jetten A. M., Vogels G. D. Nature and properties of a Staphylococcus epidermidis bacteriocin. J Bacteriol. 1972 Oct;112(1):243–250. doi: 10.1128/jb.112.1.243-250.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Jetten A. M., Vogels G. D., de Windt F. Production and purification of a Staphylococcus epidermidis bacteriocin. J Bacteriol. 1972 Oct;112(1):235–242. doi: 10.1128/jb.112.1.235-242.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sanders E. Bacterial interference. I. Its occurrence among the respiratory tract flora and characterization of inhibition of group A streptococci by viridans streptococci. J Infect Dis. 1969 Dec;120(6):698–707. doi: 10.1093/infdis/120.6.698. [DOI] [PubMed] [Google Scholar]
  11. Sprunt K., Leidy G. A., Redman W. Prevention of bacterial overgrowth. J Infect Dis. 1971 Jan;123(1):1–10. doi: 10.1093/infdis/123.1.1. [DOI] [PubMed] [Google Scholar]
  12. Sprunt K., Redman W. Evidence suggesting importance of role of interbacterial inhibition in maintaining balance of normal flora. Ann Intern Med. 1968 Mar;68(3):579–590. doi: 10.7326/0003-4819-68-3-579. [DOI] [PubMed] [Google Scholar]
  13. Tagg J. R., Dajani A. S., Wannamaker L. W. Bacteriocin of a group B streptococcus: partial purification and characterization. Antimicrob Agents Chemother. 1975 Jun;7(6):764–772. doi: 10.1128/aac.7.6.764. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tagg J. R., Dajani A. S., Wannamaker L. W., Gray E. D. Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med. 1973 Nov 1;138(5):1168–1183. doi: 10.1084/jem.138.5.1168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tagg J. R., Read R. S., McGiven A. R. Bacteriocin of a group A streptococcus: partial purification and properties. Antimicrob Agents Chemother. 1973 Sep;4(3):214–221. doi: 10.1128/aac.4.3.214. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES